SOURCE: DSM N.V.

October 18, 2007 02:15 ET

DSM successfully issued a EUR 750 million bond

HEERLEN, NETHERLANDS--(Marketwire - October 18, 2007) -



Royal DSM N.V. has issued a EUR 750 million 5.25% bond due 2017. The high demand from investors exceeded the company's optimistic expectation. The order book had an exceptionally high quality and totalled over EUR 5 billion and was closed early.

The main purpose of the debt issue is refinancing a bond maturing on December 7th, 2007 of EUR 400 million and the remaining proceeds will be used for other general corporate purposes, including the share repurchase program.

The terms of the notes are laid down in the EUR 2 billion Debt Issuance Program of Royal DSM N.V. and the supplement thereto, which is available on the Investor Relations website.

The bond is listed on the AEX as of today.

This announcement is neither an offer to sell nor a solicitation of an offer to buy any securities. The notes are being offered only by means of a prospectus.


DSM

DSM creates innovative products and services in Life Sciences and Materials Sciences, contributing to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and enjoyable way of living. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics & electronics, life protection and housing. The company strategy, Vision 2010 - Building on Strengths, focuses on accelerating profitable and innovative growth of the company's specialties portfolio. The key drivers of this strategy are market-driven growth and innovation, an increased presence in emerging economies and operational excellence. DSM has annual sales of almost EUR 9 billion and employs some 22,000 people worldwide. The company is headquartered in the Netherlands, with locations in Europe, Asia, the Americas, Africa and Australia. More information on DSM can be found at www.dsm.com.


For more information:
DSM Corporate Communications               DSM Investor Relations
Elvira Luykx                               Hans Vossen
tel. +31 (0) 45                            tel. +31 (0) 45 5782020
5782035                                    fax +31 (0) 45 5782595
fax +31 (0) 45                             e-mail
5740680                                    investor.relations@dsm.com
e-mail media.relations@dsm.com





Copyright © Hugin ASA 2007. All rights reserved.

Contact Information